Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions
Abstract
Authors
B. Ruiz-Antorán J.M. Pascasio F. Gea R. Barcena J. Larrubia Álvarez R. Pérez J. Sousa Gómez M. Romero R. Solá la Revilla. J. de J. Crespo J. Navarro J. Arenas M. Delgado Rodríguez C. Fernández R Planas M. Buti X. Forns J.L. Calleja